Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 26/2/2020
SIETES contiene 92916 citas

 
 
 1 a 7 de 7 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Bally M, Dendukuri N, Rich B, Nadeau L, Helin-Salmivaara A, Garbe E, Brophy JM. Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. BMJ 2017;357:j1909. [Ref.ID 101568]
2. Cita con resumen
Korhonen MJ, Ruokoniemi P, Ilomäki J, Meretoja A, Helin-Salmivaara A, Huupponen R. Adherence to statin therapy and the incidence of ischemic stroke in patients with diabetes. Pharmacoepidemiol Drug Saf 2016;25:161-9. [Ref.ID 100096]
3. Cita con resumen
Ruokoniemi P, Sund R, Arffman M, Helin-Salmivaara A, Huupponen R, Keskimäki I, Vehko T, Korhonen MJ. Are statin trials in diabetes representative of real-world diabetes care: a population-based study on statin initiators in Findland. BMJ Open 2014;4:e005402. [Ref.ID 97211]
4. Cita con resumen
Ruokoniemi P, Helin-Salmivaara A, Klaukka T, Neuvonen PJ, Huupponen R. Shift of statin use towards the elderly in 1995-2005: a nation-wide register study in Finland. Br J Clin Pharmacol 2008;66:405-10. [Ref.ID 83925]
5.
Helin-Salmivaara A, Huttunen T, Grönroos JM, Klaukka T, Huupponen R. Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case-control study in the general population. Eur J Clin Pharmacol 2007;63:403-8. [Ref.ID 79820]
6. Cita con resumen
Helin-Salmivaara A, Martikainen JE. At-risk patients still predisposed for myocardial infarction by coxibs. Eur J Clin Pharmacol 2007;63:97-8. [Ref.ID 79054]
7. Cita con resumen
Helin-Salmivaara A, Huupponen R, Klaukka T. Utilization of non-steroidal anti-inflammatory drugs in Finland. Pharmacoepidemiol Drug Saf 2002;11:S155-6. [Ref.ID 62136]
Seleccionar todas
 
 1 a 7 de 7